摘要
The objective of the study is to find out the effect of shark chondroitin on T lymphocyte subsets in cancer patients. Patients were divided into two groups. One group was treated with chemotherapy alone, and the other group was treated with chemotherapy plus shark chondroitin. Using immunofluorescence technique, T lymphocyte subsets in the peripheral blood were determined in two groups before and after chemotherapy. The results showed that CD4 +/CD8 + ratio increased in the patients received shark chondroitin. In the chemotherapy group, CD3 + had no change, but CD4 + decreased while CD8 + increased significantly. The results suggest that shark chondroitin could enhance immune function in cancer patients, especially during chemotherapy.
The objective of the study is to find out the effect of shark chondroitin on T lymphocyte subsets in cancer patients. Patients were divided into two groups. One group was treated with chemotherapy alone, and the other group was treated with chemotherapy plus shark chondroitin. Using immunofluorescence technique, T lymphocyte subsets in the peripheral blood were determined in two groups before and after chemotherapy. The results showed that CD4 +/CD8 + ratio increased in the patients received shark chondroitin. In the chemotherapy group, CD3 + had no change, but CD4 + decreased while CD8 + increased significantly. The results suggest that shark chondroitin could enhance immune function in cancer patients, especially during chemotherapy.
出处
《中国实验血液学杂志》
CAS
CSCD
2001年第1期95-96,共2页
Journal of Experimental Hematology
关键词
鲨鱼软骨素
T淋巴细胞亚群
肿瘤
化疗
shark chondroitin T lymphocyte subsets cancer chemotherapy
